This image shows the CMR Surgical Versius surgical robotics system in action in a operation room.
CMR Surgical’s Versius surgical robotics system in action [Image courtesy of CMR Surgical]

CMR Surgical announced today that it launched an integrated fluorescence imaging system with its Versius Plus surgical robot.

Surgeons using Versius Plus, the latest version of the company’s technology, can now use this technology to visualize ICG (indocyanine green). This system — called vLimeLite — enhances the visual assessment of the vessels, blood flow and related tissue perfusion, plus biliary anatomy.

Cambridge, UK-based CMR Surgical called vLimeLite a unique feature within surgical robotics. The company says it allows for the visualization of ICG with a choice of viewing mode for surgeons. They can choose overlay in full color or greyscale, plus they can choose green or cyan for the ICG color.

Mark Slack, co-founder and chief medical officer, said in a news release that this means surgeons can now see “what was once invisible to them.”

According to CMR Surgical, Versius Plus became the first CE-marked surgical robot to offer this type of integrated ICG system. The company said it marks the first product launch in a series of 2024 product releases to comprise Versius Plus. CEO Supratim Bose recently spoke to MassDevice about the company’s future plans for growth.

Gloucestershire Royal Hospitals NHS Trust in the UK is the first hospital to install vLimeLite. Its upper GI team plans to begin cases with the system next month.

“With 3D HD visualization, surgeons already have a fantastic view of their operating field at our Versius console,” Bose said. “But now, with vLimeLite they can see beyond what the eye can see, allowing them to clearly visualise critical anatomy during their operations.”

“This is the most significant update of Versius since it launched back in 2019. We have listened to the needs of surgeons, and I’m delighted that we have been able to give them what they want – a best-in-class ICG product that we know will make a real difference for their patients.”